About CG 210, this is a special skincare, research product of Legacy Healthcare, manufactured in France and has a globally unique mechanism of action by restoring the normal balance in the life cycle of hair growth.

This action is due to the reintroduction of the BCL-2 protein levels to normal.

(Protein BCL-2 regulates the natural cellular death. Failure of BCL-2 protein in the roots of the bristles causes premature death and apoptosis.)

            The transition to the normal cycle becomes progressively extending the duration of the anagen phase and thus the hair grow and shed a normal pace as before the appearance of hair loss.

The CG 210 is equivalent effective in men and women, comes in two different packages and ensures high levels of satisfaction in stopping hair loss and restore the density of hair growth.